Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Seelos Therapeutics, Inc. - Common Stock (NQ: SEEL )

1.280 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Seelos Therapeutics, Inc. - Common Stock

< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2021
Upgrades According to Roth Capital, the prior rating for Seelos Therapeutics Inc (NASDAQ: 
Via Benzinga
Seelos Therapeutics Shares Gain On FDA Approval To Add SLS-005 Regimen In HEALEY ALS Trial
The Sean M. Healey & AMG Center for ALS at Mass General received approval from the FDA and the Mass General Brigham Institutional Review Board to add SLS-005 (... 
Via Benzinga
Exposures Product Safety
Why Seelos Therapeutics' Stock Is Trading Higher Today
Seelos Therapeutics (NASDAQ:SEEL) shares are trading higher. Traders are circulating a Massachusetts General Hospital report titled 'Investigational drug SLS-005 (... 
Via Benzinga
$10 Billion Sackler Opioid Settlement Closes Chapter, Psychedelic Chapter Begins
Via FinancialNewsMedia
Psychedelic Medicine's Top CEOs: Who's Running The Biggest Companies In This Booming Industry?
By Natan Ponieman and Javier Hasse The psychedelic medicine industry is growing by leaps and bounds. Leading this charge is a group of ambitious and visionary corporate... 
Via Benzinga
Psychedelic Drug Industry Report Card For 2021
In assessing the psychedelic drug industry, a primary focus for investors is drug development. 
Via Talk Markets
25 Stocks Moving in Monday's Pre-Market Session
Gainers Greenpro Capital Corp. (NASDAQ: GRNQ) rose 48.7% to $1.13 in pre-market trading. Greenpro Capital shares gained 16% on Friday after the company announced its Angkasa-X... 
Via Benzinga
Which Psychedelic Drug Stock Category Outperformed Last Week
Which has performed best YTD, the Pure-Play Marijuana Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index? 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Field Trip Health Heads To The Nasdaq As Wall Street Opens Up To "Psychedelics Renaissance"
Excitement around psychedelics grows as major U.S. exchanges make room for more companies in the sector. On Friday, 
Via Benzinga
Psychedelics Gain More Traction as New Research Aims to Address Chronic Pain and Mental Illness
Via FinancialNewsMedia
Topics Law Enforcement
Exposures Legal
How To Invest In "Magic Mushrooms" (Psychedelics)
A look at psychedelics as stock market investment opportunities and identifying alternative strategies on how to invest. 
Via Talk Markets
Psychedelics Research FYI: Every Clinical Trial Underway Right Now Involving Public And Private Companies
This article was made possible thanks to invaluable research by Michael Haichin and Josh Hardman from Ps... 
Via Benzinga
Seelos' Single Dose Of SLS-004 Shows Reduction In Parkinson's Associated mRNA, Protein Expression
Seelos Therapeutics Inc (NASDAQ: SEEL) has announced positive in vivo data demonstrating down-regulation of SNCA mRNA and protein expression from a study of SLS-... 
Via Benzinga
The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 6) Ambrx Biopharma Inc. (NYSE:... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Opiant Pharmaceuticals (NASDAQ:OPNT 
Via Benzinga
Why Seelos Therapeutics Is Moving Today
Seelos Therapeutics, Inc. (NASDAQ: SEEL) shares are trading higher after Guggenheim analyst Yatin Suneja initiated coverage on the stock with a Buy rating and announced an $8... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 1, 2021
Upgrades Citigroup upgraded the previous rating for Thor Industries Inc (NYSE: 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Alterity Therapeutics (NASDAQ:ATHE) shares moved upwards by 60.76% to $2.09 during Thursday's pre-market session. The market value of their outstanding shares... 
Via Benzinga
Why Seelos Therapeutics Stock Is Jumping Today
The company has been included in the first U.S. psychedelics-focused ETF. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2021
Upgrades For Equity Residential (NYSE:EQR), BMO Capital upgraded the previous rating of Market Perform to Outperform. Equity Residential earned $0.68 in the first quarter... 
Via Benzinga
Seelos's Amyotrophic Lateral Sclerosis Candidate, SLS-005 An Orphan Drug In Europe
Seelos Therapeutics Inc's (NASDAQ: SEEL) Trehalose (SLS-005) has received Orphan Drug Designation for amyotrophic lateral sclerosis (ALS) from the European... 
Via Benzinga
Psyched: MindMed To Begin Mescaline Trials and Deepak Chopra Partnership, Seelos And Cybin Advance Clinical Research
MindMed’s News Spree: Mescaline Trials, Chopra Foundation Partnership and LSD Research MindMed (NASDAQ: 
Via Benzinga
Increased R&D Activities Have Fueled Growth and Promise for Pancreatic Cancer Treatment
Via FinancialNewsMedia
Topics Death
Exposures Death
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers VistaGen Therapeutics (NASDAQ:VTGN) shares moved upwards by 14.34% to $2.63 during Thursday's pre-market session. The market value of their outstanding shares... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers VistaGen Therapeutics (NASDAQ:VTGN 
Via Benzinga
CNS Pharmaceuticals Commences Patient Enrollment in Potentially Pivotal Study of Berubicin
CNS Pharmaceuticals today announced open enrollment for its potentially pivotal study evaluating the efficacy and safety of Berubicin in the treatment of recurrent GBM. 
Via Talk Markets
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Onconova Therapeutics (NASDAQ:ONTX) shares moved upwards by 41.84% to $0.88 during Tuesday's regular session. As of 12:30 EST, this security is trading at a... 
Via Benzinga
58 Biggest Movers From Yesterday
Gainers BM Technologies, Inc. (NYSE: BMTX) shares climbed 26.4% to close at $11.82 on Tuesday after the company reported record Q1 results. Ultralife Corporation (NASDAQ: ULBI)... 
Via Benzinga
42 Stocks Moving In Tuesday's Mid-Day Session
Gainers Agenus Inc. (NASDAQ: AGEN) shares surged 33.4% to $4.35. Bristol-Myers Squibb Co and Agenus entered into a global exclusive license agreement, under which Bristol Myers... 
Via Benzinga
58 Biggest Movers From Yesterday
Gainers Peabody Energy Corporation (NYSE: BTU) shares gained 32.3% to settle at $8.60 on Monday. Nuvve Holding Corp. (NASDAQ: NVVE) shares jumped 30.9% to close at $10.80 on... 
Via Benzinga
< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.